References
- Mammen EF. Congenital coagulation disorders. Semin Thromb Hemost 1983: 9(1): 1–72
- Rizza CR. ed. Congenital coagulation disorders. Clin Haematol 1979: 8(1): 3–214
- Barrai I, Cann HM, Cavalli-Sforza LL, et al. The effect of parental age on rates of mutation for hemophilia and evidence for differing mutation rates for hemophilia A and B. Am J Hum Genet 1968: 20(3): 175–96
- Tschopp TB, Weiss HJ, Baumgartner HR. Decreased adhesion of platelets to sub-endothelium in von Willebrand's disease. J Lab Clin Med 1974: 83(2): 296–300
- Shapiro SS, Hultin MB. Acquired inhibitors to the blood coagulation factors. Semin Thromb Hemost 1975: 1(1): 336–85
- Losowsky MS, Simmons AV, Miloszewski K. Coagulation abnormalities in liver disease. Postgrad Med 1973: 53(1): 147–52
- O'Reilly RA, Aggeler PM. Covert anticoagulant ingestion: study of 25 patients and review of the world literature. Medicine (Baltimore) 1976: 55(5): 389–99
- Shapiro SS, Thiagarajan P. Lupus anticoagulants. Prog Hemost Thromb 1962: 6: 263–85
- Berkman SA. Infectious complications of blood transfusions. Semin Oncol 1984: 11(1): 68–76
- Lusher JM, Shapiro SS, Palascak JE, et al. Efficacy of prothrombin-complex concentrates in hemophiliacs with antibodies to factor VIII: a multicenter therapeutic trial. N Engl J Med 1980: 303(8): 421–5
- White GC, Lundblad RL, Kingdon HS. Prothrombin complex concentrates: preparation, properties, and clinical uses. Curr Top Hematol 1979: 2: 203–44
- Inwood MJ, Killackey B, Startup SJ. The use and safety of ibuprofen in the hemophiliac. Blood 1983: 61(4): 709–11
- Francis RB Jr, Kasper CK. Reproduction in hemophilia. JAMA 1983: 250(23): 3192–5